RHHBY - Hot Stocks: Cannabis rally; CLX low; DNA BROS find investors; AVIR plunges on COVID fail
In a session where the major averages posted ho-hum gains, Canadian cannabis stocks proved a source of excitement on Tuesday. A mention on CNBC sparked a midday rally in Tilray (NASDAQ:TLRY), which pulled much of the rest of the sector higher with it. Canopy Growth (NASDAQ:CGC), Aurora Cannabis (NASDAQ:ACB) and Cronos (NASDAQ:CRON) all recorded notable gains as well. Elsewhere, a couple of recent additions to the Wall Street family recorded standout advances. Ginkgo Bioworks (NYSE:DNA) and Dutch Bros (NYSE:BROS) both jumped on signs of broadening support among investors. Tuesday also had its share of major losers. Atea Pharmaceuticals (NASDAQ:AVIR) was among these, losing about two-thirds of its value after its COVID treatment failed in a clinical trial. Meanwhile, Clorox (NYSE:CLX) didn't have the same kind of dramatic freefall, but worries about inflation pushed the stock below a recent range and to a new 52-week low. Sector In Focus A positive
For further details see:
Hot Stocks: Cannabis rally; CLX low; DNA, BROS find investors; AVIR plunges on COVID fail